Stable, recombinant AequoScreen® cell line expressing aequorin and the Prokineticin recetpor 2 (PKR2), human recombinant in CHO-K1 host cells.
false falseCell Line Terms and Conditions must be accepted before orders are placed. Additional agreement needed for commercial use.
PerkinElmer’s AequoScreen® double transfected cell lines are provided in two vials of frozen cells, each containing ∽2.5 x 106 cells. Detailed product information as well as recommended cell culture conditions and validation assay date are available for each cell line.
The AequoScreen technology is a generic GPCR technology that can be used with Gs, Gi, and Gq-coupled GPCRs and calcium coupled ion channels. Following receptor stimulation, increases in intracellular calcium enable measurement of the resulting flash luminescence signal.
Features:
PerkinElmer’s AequoScreen cell lines require accepted cell line Terms and Conditions prior to order processing. Additional agreement needed for commercial use. Contact us using the Request More Information button above for additional information regarding required documentation.
Assay Target Class | GPCR |
---|---|
Assay Validated | Binding, Calcium Luminescence, Calcium Flourescence |
Automation Compatible | Yes |
Host | CHO-K1 |
Product Brand Name | AequoScreen |
Receptor Type | Prokineticin |
Shipping Condition | Dry Ice |
Special Ordering Information | Requires accepted Terms and Conditions. Additional agreement needed for commercial use. |
Unit Size | 5 million |